BOLAND E W, HEADLEY N E
Calif Med. 1951 Jun;74(6):416-23.
The administration of cortisone acetate to patients with rheumatoid arthritis usually produces prompt and often dramatic suppression of the disease manifestations. The effects of the hormone are not lasting, however, and after withdrawal relapse ensues. For sustained improvement in a chronic disease such as rheumatoid arthritis, it appears that cortisone must be given more or less continuously. This raises the question whether administration may be continued effectively and safely for long periods.Seventy-six patients with rheumatoid arthritis were given cortisone in the hope that treatment could be continued uninterruptedly for extended periods. For various clinical reasons it was necessary to discontinue treatment in 16 of these before six months, but the remaining 60 patients received the hormone uninterruptedly for six to 15 months. By using initial large suppressive amounts, then gradually reducing the dosage, and finally employing smaller maintenance doses, adequate degrees of rheumatic control were maintained in approximately two-thirds of the original 76 patients. The ability to sustain satisfactory improvement varied indirectly, in general, with the severity of the rheumatoid arthritis. The chief detriment to better results in the more severe cases was the intervention of adverse hormonal side effects which developed frequently when large or relatively large maintenance doses were required to support satisfactory improvement. Unwanted signs of hormonal excess developed in 40 per cent of cases at some time during the course of treatment. Most of them were mild or transient and disappeared or lessened when the dose of cortisone was reduced, but when the dose was reduced the degree of improvement often declined also. During prolonged cortisone therapy evidence of functional suppression of the adrenal cortices, as indicated by a decreased response of circulating eosinophils to exogenous ACTH, was present. The depression of cortical function was temporary, however. Whether irreversible damage may result when the drug is employed for longer periods cannot yet be answered.
给类风湿性关节炎患者服用醋酸可的松通常会迅速且常常显著地抑制疾病表现。然而,这种激素的效果并不持久,停药后病情会复发。对于类风湿性关节炎等慢性疾病的持续改善,似乎必须或多或少持续给予可的松。这就提出了一个问题,即长期给药是否能有效且安全地持续进行。76名类风湿性关节炎患者接受了可的松治疗,希望能长期不间断地进行治疗。由于各种临床原因,其中16名患者在6个月前就有必要停药,但其余60名患者连续6至15个月接受了这种激素治疗。通过最初使用大剂量的抑制量,然后逐渐减少剂量,最后采用较小的维持剂量,在最初的76名患者中约三分之二维持了足够程度的风湿控制。总体而言,维持满意改善的能力与类风湿性关节炎的严重程度呈间接变化。在更严重的病例中,影响更好治疗效果的主要不利因素是不良激素副作用的干预,当需要大剂量或相对大剂量的维持剂量来支持满意的改善时,这种副作用经常出现。在治疗过程中的某个时候,40%的病例出现了激素过量的不良迹象。大多数症状轻微或短暂,当可的松剂量减少时会消失或减轻,但当剂量减少时,改善程度往往也会下降。在长期可的松治疗期间,出现了肾上腺皮质功能抑制的证据,表现为循环嗜酸性粒细胞对外源性促肾上腺皮质激素的反应降低。然而,皮质功能的抑制是暂时的。当使用该药物更长时间时是否会导致不可逆转的损害,目前还无法回答。